Skip to main navigation Skip to search Skip to main content

Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients with Advanced Neuroendocrine Tumors

  • ENTIRE Endocrine Neoplasia Translational Research Center
  • Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients with Advanced Neuroendocrine Tumors'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Neuroscience

Psychology

Immunology and Microbiology